Prothena’s Top Scientist Kinney Expands Role To COO

Xconomy San Francisco — 

Prothena (NASDAQ: PRTA) has named Gene Kinney as its chief operating officer, a new position at the drug developer. Kinney has been chief scientific officer and head of R&D since the company launched in 2012. He will keep those titles. Prothena is domiciled in Dublin, Ireland, but conducts daily operations in South San Francisco, CA.